Arlene Naranjo Selected Research

Ganglioneuroblastoma

1/2017	Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.
3/2013	Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee.
10/2009	Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arlene Naranjo Research Topics

Disease

59	Neuroblastoma 04/2024 - 07/2009
34	Neoplasms (Cancer) 11/2023 - 10/2009
4	Wilms Tumor (Wilm's Tumor) 01/2019 - 01/2013
3	Fever (Fevers) 12/2022 - 01/2017
3	Ganglioneuroblastoma 01/2017 - 10/2009
2	Hypersensitivity (Allergy) 12/2022 - 01/2018
2	Hypotension (Low Blood Pressure) 12/2022 - 01/2018
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 10/2021 - 01/2021
2	Residual Neoplasm 01/2020 - 10/2019
2	Disease Progression 12/2017 - 11/2016
2	Ganglioneuroma 03/2013 - 10/2009
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2021
1	Hypertrophy 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Hepatomegaly 10/2019
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 01/2018
1	Capillary Leak Syndrome 01/2018
1	Neuralgia (Stump Neuralgia) 01/2018
1	Neoplasm Metastasis (Metastasis) 11/2017
1	Pain (Aches) 01/2017
1	Neutropenia 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2017
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2017
1	Infections 01/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2016
1	Ascites 02/2013
1	Rupture 02/2013

Drug/Important Bio-Agent (IBA)

11	3-Iodobenzylguanidine (Iobenguane)IBA 08/2023 - 07/2011
9	dinutuximabIBA 01/2023 - 01/2017
8	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023 - 01/2018
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2012
6	Interleukin-2 (IL2)IBA 12/2022 - 01/2018
6	Isotretinoin (Accutane)FDA LinkGeneric 10/2019 - 01/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 09/2012
4	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2015
4	N-Myc Proto-Oncogene ProteinIBA 01/2021 - 03/2013
4	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2019 - 01/2012
3	LigandsIBA 01/2023 - 01/2017
3	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2009
3	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 01/2017
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 01/2017
3	Messenger RNA (mRNA)IBA 01/2022 - 12/2011
3	Protein Isoforms (Isoforms)IBA 01/2017 - 04/2011
2	Topotecan (Hycamtin)FDA LinkGeneric 11/2023 - 11/2011
2	temsirolimus FDA Link 01/2023 - 01/2017
2	Melphalan (Alkeran)FDA LinkGeneric 10/2021 - 01/2021
2	Busulfan (Busulfex)FDA Link 10/2021 - 01/2021
2	CytokinesIBA 01/2021 - 10/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020 - 01/2020
2	Tumor Biomarkers (Tumor Markers)IBA 01/2020 - 01/2019
2	CarbonIBA 01/2020 - 10/2016
2	VitaminsIBA 01/2019 - 10/2016
2	CatecholaminesIBA 11/2017 - 01/2017
2	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 07/2016 - 03/2016
2	Indicators and Reagents (Reagents)IBA 04/2013 - 02/2013
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2012 - 04/2011
1	Antineoplastic Agents (Antineoplastics)IBA 11/2023
1	GD2 gangliosideIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	GangliosidesIBA 01/2020
1	lorukafusp alfaIBA 10/2019
1	Vitamin A (Retinol)FDA LinkGeneric 01/2019
1	ProteomeIBA 01/2019
1	ProhibitinsIBA 01/2019
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2019
1	Interleukin-5 (Interleukin 5)IBA 01/2018
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018
1	NitratesIBA 01/2018
1	Prednisone (Sone)FDA LinkGeneric 01/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2018
1	thiamine triphosphorate (TTP)IBA 12/2017
1	Rituximab (Mabthera)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	HLA-Bw4 antigenIBA 01/2017
1	Neurotransmitter Agents (Neurotransmitter)IBA 11/2016
1	Neuropeptide YIBA 11/2016
1	Choline (Choline Chloride)IBA 10/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2016
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2015
1	Peptides (Polypeptides)IBA 04/2014
1	SaltsIBA 03/2013
1	MethyltransferasesIBA 09/2012

Therapy/Procedure

31	Therapeutics 10/2023 - 07/2009
10	Drug Therapy (Chemotherapy) 04/2024 - 11/2011
9	Immunotherapy 01/2023 - 01/2017
8	Induction Chemotherapy 12/2021 - 11/2012
3	Stem Cell Transplantation 01/2021 - 04/2013
3	Nephrectomy 02/2015 - 01/2013
2	Radiotherapy 01/2020 - 11/2016
2	Operative Surgical Procedures 01/2014 - 10/2009
1	Transplantation 08/2023
1	Aftercare (After-Treatment) 01/2020
1	Duration of Therapy 12/2019
1	Hematopoietic Stem Cell Transplantation 12/2017
1	Central Venous Catheters 10/2014
1	Biological Therapy 06/2013
1	Nephroureterectomy 01/2013
1	Thrombectomy 01/2013